Please make sure your browser supports JavaScript and cookies and that you are not blocking them from loading. Why did this happen? For more information you can review our Terms of Service and Cookie Policy. Eliquis, which made up about 21% of the companys total sales in the latest reported quarter, faces U.S. market exclusivity loss after 2026. Eliquis, which made up about 21% of the companys total sales in the latest reported quarter, faces U.S. market exclusivity loss after 2026.
Eliquis, which made up about 22% of the firm's sweepstakes winnings.
( z0 product :name ( z1 name :op "Eliquis" ) :ARG1-of ( z2 include :ARG2 ( z3 win :ARG0 ( z4 firm ) :ARG3 ( z5 sweep ) ) :ARG3 ( z6 percentage-entity :value 22 ) ) )
(z0 / product
    :name (z1 / name
              :op1 "Eliquis")
    :ARG1-of (z2 / include-91
                 :ARG2 (z3 / win-01
                           :ARG0 (z4 / firm)
                           :ARG3 (z5 / sweep-01))
                 :ARG3 (z6 / percentage-entity
                           :value 22)))
Eliquis , which made up about 22 % of the firm 's sweepstakes winnings .
z0 :name z1
z1 :op1 1
z6 :value 0
z2 :ARG3 z6
z0 :ARG1-of z2
z3 :ARG3 z5
z3 :ARG0 z4
z2 :ARG2 z3